Periodic Congress

Confirmed speakers

Andrea Ablasser

Global Health Institute, EPFL, Switzerland


Kaan Boztug

Director, Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases 
Scientific Director, Children’s Cancer Research Institute / St Anna Kinderkrebsforschung

Adjunct PI, CeMM Research Center for Molecular Medicine, Austrian Academy of Sciences
Associate Professor of Pediatrics and Adolescent Medicine, Medical University of Vienna
Consultant in Pediatric Hematology, Oncology and Immunology, St. Anna Children’s Hospital Vienna

Paul Brogan

Great Ormond Street Hospital (GOSH), United Kingdom

Dr Paul Brogan works in the department of Rheumatology at Great Ormond Street Hospital (GOSH) and is section head for Infection, Inflammation and Rheumatology in the UCL Institute of Child Health (ICH).

He has developed a successful clinical and academic programme of work dedicated to the developing field of paediatric vasculitis and autoinflammatory diseases, in concert with a world-leading clinical service for these rare diseases as Chair of the Vasculitis Consortium and Clinical Lead for Autoinflammatory Disease at GOSH.

Lauren Henderson

Boston Children's Hospital, USA

Dr. Lauren Henderson is an Attending Physician in Rheumatology at Boston Children’s Hospital and an Instructor in Pediatrics at Harvard Medical School. She oversees the daily operations of the New-onset JIA Registry and the Rheumatic Diseases of Childhood Biorepository at Boston Children’s Hospital. In addition, she serves as the subcommittee chair for the CARRA (Childhood Arthritis and Rheumatology Research Alliance) federated biorepository that includes more than 60 pediatric rheumatology sites in the US and Canada. Her research focuses on the role of regulatory T cells in the pathogenesis of juvenile idiopathic arthritis. 

Dan Kastner

National Human Genome Research Institute, USA

Dr. Dan Kastner obtained his A.B. summa cum laude in philosophy from Princeton University in 1973 and a Ph.D. and M.D. from Baylor College of Medicine by 1982. After completing Internal Medicine residency and chief residency at Baylor, Dan moved to the National Institutes of Health (NIH) in 1985. He is currently the Scientific Director of the Division of Intramural Research of the National Human Genome Research Institute (NHGRI). Throughout his career at the NIH Dan’s research has focused on using genetic and genomic strategies to understand inherited disorders of inflammation, often stimulated by patients with relatively rare disorders seen at the NIH Clinical Center hospital. This work has provided detailed molecular explanations for these illnesses, has provided the conceptual basis for highly effective targeted therapies, and has informed our understanding of more common illnesses. Dan’s group also proposed the now widely accepted overarching concept of autoinflammatory disease to denote disorders of the evolutionarily ancient innate branch of the human immune system. Dan has won a number of awards and honors, including election to the National Academy of Sciences in 2010 and to the National Academy of Medicine in 2012, recognition as Federal Employee of the Year in 2018, and the Ross Prize in Molecular Medicine in 2019.
Isabelle Koné-Paut

Helen Lachmann

University College London, United Kingdom

Dr. Helen Lachmann is Honorary Consultant Nephrologist  at University College London (UCL). She completed her Bachelor’s degree from University of Cambridge and M.D from University College London.

Dr. Helen Lachmann specialises in amyloidosis and auto-inflammatory diseases. She has published widely and her main scientific interests are focused on the phenotypic characterisation and treatment of acquired and hereditary forms of systemic amyloidosis and the genetics and management of inherited systemic auto-inflammatory conditions. 

Maria Cecilia Poli Harlowe

Universidad del Desarrollo, Chile

Sinisa Savic

University of Leeds, United Kingdom

Prof Savic leads translational research programmes focused on the discovery of molecular mechanisms which underpin the pathogenesis of primary immunodeficiencies (PID) and systemic autoinflammatory disorders (SAID), both hereditary and acquired. This includes the application of modern genetic techniques such as whole genome sequencing to aid the discovery of novel genetic causes, and the use of functional assays to determine the relevance of novel genetic variants on immune system function. 

Chris Scott

University of Cape Town, South Africa


About us

IssaidThe International Society of Systemic Auto-Inflammatory Diseases (ISSAID) raise awareness, catalyse basic research and promote scientific and clinical knowledge on all aspects of systemic auto-inflammatory diseases.

Contact Information

ISSAID 2021 c/o MCI Geneva
9, rue du Pré-Bouvier
1242, Satigny, Geneva


Official Website:

By continuing to browse this website, you accept cookies which are used to offer a personalized experience on our website, generate statistics and realize advertising or social network tracking. Find out more about our Privacy policy and how to manage them on your browser. You can change your cookie settings at any time.    

Cookie PolicyAccept